BUTYLPARABEN

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
194.0 2.3 1 3 47.0 4 0.36
CAS
94268
UNII
3QPI1U3FV8
SYNONYMS
ZINC ID(s)
Availability
Present in 64 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
Code Date Title Phase Status
NCT01951417 2013-10-01 Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris Phase 4 Completed
NCT01909713 2013-05-01 Tolerability of a Foaming Facial Cleanser and Moisturizer SPF 30 in a Pediatric Population (7-11) With Acne Prone Skin. Phase 4 Completed
NCT01256203 2013-05-01 Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light Phase 2 Withdrawn
NCT01656226 2012-07-01 Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis Phase 4 Active, Not Recruiting
NCT01240746 2010-11-01 Study of Quadrivalent Influenza Vaccine Among Children Phase 3 Completed
NCT01001975 2009-07-01 Determination of Sun Protection in Sunscreen Formulas (Study SR09-15)(P08236)(COMPLETED) Phase 3 Completed
NCT00693641 2008-07-01 Efficiency of a Jellyfish Sting Inhibitor Sun Lotion and Protocols for Jellyfish Sting Pain Relief Phase 4 Completed
NCT01892657 2008-03-01 Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test Phase 4 Completed
NCT00362986 2006-10-01 Topical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for Cancer Phase 3 Completed
NCT00343915 2004-04-01 Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs Phase 3 Completed

(Browse) Purchasable Analogs in ZINC

Dosages

Route Formulation Per Unit Dose
Intramuscular Injection
Oral Capsule 0.002MG
Oral Capsule, Sustained Action
Oral Emulsion
Oral Tablet, Coated 0.004MG
Oral Tablet, Extended Release
Oral Tablet, Repeat Action 0.01MG
Oral Tablet, Sustained Action 0.04MG
Oral Tablet, Sustained Action, Coated
Topical Ointment
Oral Drops
Oral Liquid
Oral Solution
Oral Solution, Syrup
Oral Suspension
Oral Syrup
Rectal Liquid
Rectal Solution
Topical Cream, Emulsion, Sustained Release
Topical Emulsion, Cream
Topical Lotion

More Information

Usage Over Time

Comments